Association of transforming growth factor-β1 gene polymorphisms with genetic susceptibility to acute myocardial infarction

American Journal of the Medical Sciences

Volumn 342, Issue 5, 2011, Pages 365-370

  Najar, Reza Akbarzadeh ^a   Ghaderian, Sayyed Mohammad Hossein ^a   Panah, Akram Sadat Tabatabaei ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Acute myocardial infarction; Polymorphism; Serum concentrations; Transforming growth factor 1

Indexed keywords

GENOMIC DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 80055059778     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318215908a     Document Type: Article

References (34)

1. Jennings RB, Murry CE, Steenbergen C Jr, et al. Development of cell injury in sustained acute ischemia. Circulation 1990;82:112-13.
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-20. (Pubitemid 29523224)
4. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-8. (Pubitemid 30408720)
5. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-45. (Pubitemid 17198877)
6. Kurihara H, Yoshizumi M, Sugiyama T, et al. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989;159:1435-40. (Pubitemid 19101142)
7. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92. (Pubitemid 24333194)
8. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996;28:881-7. (Pubitemid 26365534)
9. Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-20. (Pubitemid 28513380)
10. Dubois CM, Laprise MH, Blanchette F, et al. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 1995;270:10618-24.
11. Syrris P, Carter ND, Metcalfe JC, et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 1998;95:659-67. (Pubitemid 29034430)
12. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999;8:93-7. (Pubitemid 29039053)
13. Yokota M, Ichihara S, Lin TL, et al. Association of a T29-C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-7. (Pubitemid 30396007)
14. Wang XL, Sim AS, Wilcken DE. A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease. Clin Sci (Lond) 1998;95:745-6. (Pubitemid 29034440)
15. Koch W, Hoppmann P, Mueller JC, et al. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol 2006;26:1114-9. (Pubitemid 43732120)
16. Peng Q, Chunfang G, Meng F, et al. Establishment of a real-time PCR for quantifying transforming growth factor beta1 in blood of hepatocellular carcinoma patients. J Med Coll PLA 2008;23:228-36.
17. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-6. (Pubitemid 24106561)
18. Nora JJ, Lortscher RH, Spangler RD, et al. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980;61:503-8. (Pubitemid 10179693)
19. Thompson NL, Bazoberry F, Speir EH, et al. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1988;1:91-9. (Pubitemid 19144100)
20. Dean RG, Balding LC, Candido R, et al. Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem 2005;53:1245-56. (Pubitemid 41331123)
21. Cipollone F, Fazia M, Mincione G, et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke 2004;35:2253-7. (Pubitemid 39311245)
22. Nikol S, Isner JM, Pickering JG, et al. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 1992;90:1582-92.
23. Ohji T, Urano H, Shirahata A, et al. Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb Haemost 1995;73:812-8.
24. Kanzaki T, Tamura K, Takahashi K, et al. In vivo effect of TGFbeta Enhanced intimal thickening by administration of TGF-beta 1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol 1995;15:1951-7.
25. Wang XL, Liu SX, Wilcken DE. Circulating transforming growth factor beta 1 and coronary artery disease. Cardiovasc Res 1997;34: 404-10. (Pubitemid 27241586)
26. Silverman ES, Palmer LJ, Subramaniam V, et al. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004;169:214-9. (Pubitemid 38114537)
27. Suthanthiran M, Li B, Song JO, et al. Transforming growth factorbeta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000;97:3479-84. (Pubitemid 30183328)
28. Grainger DJ, Kemp PR, Metcalfe JC, et al. The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995;1:74-9.
29. Tashiro H, Shimokawa H, Yamamoto K, et al. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis 1997;8:143-7. (Pubitemid 27281077)
30. Batuman O, Go D, Clark LT, et al. Relationship between cytokine levels and coronary artery disease in women. Heart Dis 2001;3:80-4. (Pubitemid 33131480)
31. Tashiro H, Shimokawa H, Sadamatu K, et al. Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis 2002;13:139-43. (Pubitemid 34747960)
32. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
33. Schaan BD, Quadros AS, Sarmento-Leite R, et al. 'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease. Cardiovasc Diabetol 2007;6:19.
34. Grainger DJ, Wakefield L, Bethell HW, et al. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1995;1:932-7.